Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2559-2025

Chemistry Products LAC Slides. Recall

Chemistry Products LAC Slides. Catalog Number: 8433880. 1 Sales Unit = contains 5 cartridges of 60 slides, for a total of 300 tests.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Chemistry Products LAC Slides.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2559-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 29, 2025
FDA report date
Sep 24, 2025
Quantity in commerce
2,908 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Chemistry Products LAC Slides. Catalog Number: 8433880. 1 Sales Unit = contains 5 cartridges of 60 slides, for a total of 300 tests.

Affected model & UDI checker

Search the exact identifiers published for Z-2559-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
8433880Chemistry Products LAC Slides.Check source noticeNot specified
FDA code information

Catalog number 8433880; UDI# 110758750004911; Coating 0130 and above, this includes Lot numbers 3533-0130-2317, 3533-0130-2717, 3533-0130-2718, 3533-0130-2719, 3533-0130-4546, 3533-0130-4605, 3533-0131-4763, 3533-0131-6114, 3533-0131-6115, 3533-0131-6116, 3533-0131-6128; Expiration date range 01-Sep-2026 to 01-Jan-2027

View the original FDA recall notice

Why was this product recalled?

VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above with Condition Code TH4-63J during calibration, causing the delay of lac test results and potentially impact patient management. The issue was identified by QuidelOrtho through an increase in customer complaints compared to the historical baseline with average failure rate of 1% for coating 0130 in 2025 while average of failure rate for other coating was 0.06% in 2025 and average of failure rate for all coatings is 0.03% for 2024.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did ORTHO-CLINICAL DIAGNOSTICS, INC. take?

On 29 July 2025, QuidelOrtho mailed a hardcopy customer letter (Ref. CL2025-201) via FedEx overnight courier and/ or electronically sent the customer letter using ORTHO PLUS e-Communications to customers. Consignees were instructed to load ADD DRV 6339 (or above) on your VITROS XT 3400 and/or VITROS XT 7600 System(s), complete and return the provided Confirmation of Receipt, save the notification with your User Documentation or post this notification by each VITROS XT 3400/VITROS XT 7600 System in your laboratory until the issue has been resolved, and forward the information if affected units were further distributed.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology